Healthcare · Industry
Drug Manufacturers - Specialty & Generic - List & Prices (97 stocks)
All 97 Drug Manufacturers - Specialty & Generic stocks listed, ranked by market capitalization — 2 page(s), 50 per page.
What Are the Leading Drug Manufacturers - Specialty & Generic Stocks?
Prices: Oct 21, 2026 close Last Updated: Oct 21, 2026There are 97 publicly traded Drug Manufacturers - Specialty & Generic stocks. The largest by market capitalization are TAK, TEVA, HLN, ZTS, UTHR, VTRS, NBIX, ELAN, RDY, APTX.TO.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | TAK | $19.93 | $63.67B | 3.07% | |
| Teva Pharmaceutical Industries Limited | TEVA | $40.62 | $47.37B | 67.7 | — |
| Haleon plc | HLN | $10.02 | $44.06B | 20.5 | 1.95% |
| Zoetis Inc. | ZTS | $79.62 | $32.90B | 13.1 | 2.65% |
| United Therapeutics Corporation | UTHR | $563.49 | $24.17B | 20.2 | — |
| Viatris Inc. | VTRS | $18.45 | $21.19B | 2.57% | |
| Neurocrine Biosciences, Inc. | NBIX | $141.31 | $14.36B | 20.7 | — |
| Elanco Animal Health Incorporated | ELAN | $22.55 | $11.26B | — | |
| Dr. Reddy's Laboratories Limited | RDY | $13.19 | $10.99B | 30.0 | 0.63% |
| Apotex Health Corp. | APTX.TO | CA$33.23 | CA$7.59B | 0.18% | |
| Alkermes plc | ALKS | $43.48 | $7.29B | 114.4 | — |
| Amneal Pharmaceuticals, Inc. | AMRX | $20.20 | $7.04B | 41.2 | — |
| Hims & Hers Health, Inc. | HIMS | $29.21 | $6.82B | — | |
| Lantheus Holdings, Inc. | LNTH | $100.24 | $6.55B | 24.3 | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | $79.70 | $6.22B | 80.5 | — |
| Regencell Bioscience Holdings Limited | RGC | $10.80 | $5.36B | — | |
| Indivior Pharmaceuticals, Inc. | INDV | $34.79 | $4.11B | 12.5 | — |
| Amylyx Pharmaceuticals, Inc. | AMLX | $29.03 | $3.64B | — | |
| Liquidia Corporation | LQDA | $38.86 | $3.48B | 28.0 | — |
| Curaleaf Holdings, Inc. | CURA.TO | CA$11.38 | CA$3.01B | — | |
| HUTCHMED (China) Limited | HCM | $14.37 | $2.50B | 143.7 | — |
| Supernus Pharmaceuticals, Inc. | SUPN | $41.21 | $2.40B | — | |
| Prestige Consumer Healthcare Inc. | PBH | $47.92 | $2.27B | 13.4 | — |
| Bausch Health Companies Inc. | BHC | $6.45 | $2.20B | — | |
| Perrigo Company plc | PRGO | $15.91 | $2.20B | 7.17% | |
| Trulieve Cannabis Corp. | TRLV | $11.00 | $2.12B | — | |
| BioCryst Pharmaceuticals, Inc. | BCRX | $7.75 | $2.03B | — | |
| Xeris Biopharma Holdings, Inc. | XERS | $10.79 | $1.97B | — | |
| Alvotech | ALVO | $5.13 | $1.83B | — | |
| ANI Pharmaceuticals, Inc. | ANIP | $72.24 | $1.66B | 15.6 | — |
| Phibro Animal Health Corporation | PAHC | $39.25 | $1.59B | 16.2 | 1.24% |
| Pacira BioSciences, Inc. | PCRX | $36.33 | $1.45B | 103.8 | — |
| Eton Pharmaceuticals, Inc. | ETON | $49.30 | $1.41B | 123.3 | — |
| Cronos Group Inc. | CRON | $3.39 | $1.25B | 17.8 | — |
| Knight Therapeutics Inc. | GUD.TO | CA$11.70 | CA$1.15B | 78.0 | — |
| Amphastar Pharmaceuticals, Inc. | AMPH | $26.20 | $1.11B | 15.5 | — |
| Harrow, Inc. | HROW | $28.24 | $1.06B | — | |
| Collegium Pharmaceutical, Inc. | COLL | $22.92 | $746.01M | 18.0 | — |
| Ironwood Pharmaceuticals, Inc. | IRWD | $3.55 | $586.60M | 4.6 | — |
| Evotec SE | EVO | $1.56 | $554.41M | — | |
| Aquestive Therapeutics, Inc. | AQST | $4.08 | $512.09M | — | |
| Evolus, Inc. | EOLS | $7.40 | $488.77M | — | |
| Kamada Ltd. | KMDA | $7.78 | $448.99M | 20.5 | 2.17% |
| Tilray Brands, Inc. | TLRY | $2.92 | $431.54M | — | |
| Canopy Growth Corporation | WEED.TO | CA$0.94 | CA$422.34M | — | |
| Auxly Cannabis Group Inc. | XLY.TO | CA$3.36 | CA$346.87M | 14.0 | — |
| Cipher Pharmaceuticals Inc. | CPH.TO | CA$13.31 | CA$338.27M | 8.7 | — |
| Emergent BioSolutions Inc. | EBS | $6.20 | $317.89M | — | |
| Alpha Teknova, Inc. | TKNO | $5.85 | $314.08M | — | |
| Anika Therapeutics, Inc. | ANIK | $20.60 | $275.69M | — |
Takeda Pharmaceutical Company Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $63.67B
- P/E
- unprofitable
- Dividend Yield
- 3.07%
Teva Pharmaceutical Industries Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $47.37B
- P/E
- 67.7
Haleon plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $44.06B
- P/E
- 20.5
- Dividend Yield
- 1.95%
Zoetis Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $32.90B
- P/E
- 13.1
- Dividend Yield
- 2.65%
United Therapeutics Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $24.17B
- P/E
- 20.2
Viatris Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $21.19B
- P/E
- unprofitable
- Dividend Yield
- 2.57%
Neurocrine Biosciences, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $14.36B
- P/E
- 20.7
Elanco Animal Health Incorporated
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $11.26B
- P/E
- unprofitable
Dr. Reddy's Laboratories Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $10.99B
- P/E
- 30.0
- Dividend Yield
- 0.63%
Apotex Health Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$7.59B
- P/E
- unprofitable
- Dividend Yield
- 0.18%
Alkermes plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $7.29B
- P/E
- 114.4
Amneal Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $7.04B
- P/E
- 41.2
Hims & Hers Health, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.82B
- P/E
- unprofitable
Lantheus Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.55B
- P/E
- 24.3
Kiniksa Pharmaceuticals International, plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.22B
- P/E
- 80.5
Regencell Bioscience Holdings Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $5.36B
- P/E
- unprofitable
Indivior Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $4.11B
- P/E
- 12.5
Amylyx Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $3.64B
- P/E
- unprofitable
Liquidia Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $3.48B
- P/E
- 28.0
Curaleaf Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$3.01B
- P/E
- unprofitable
HUTCHMED (China) Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.50B
- P/E
- 143.7
Supernus Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.40B
- P/E
- unprofitable
Prestige Consumer Healthcare Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.27B
- P/E
- 13.4
Bausch Health Companies Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.20B
- P/E
- unprofitable
Perrigo Company plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.20B
- P/E
- unprofitable
- Dividend Yield
- 7.17%
Trulieve Cannabis Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.12B
- P/E
- unprofitable
BioCryst Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.03B
- P/E
- unprofitable
Xeris Biopharma Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.97B
- P/E
- unprofitable
Alvotech
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.83B
- P/E
- unprofitable
ANI Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.66B
- P/E
- 15.6
Phibro Animal Health Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.59B
- P/E
- 16.2
- Dividend Yield
- 1.24%
Pacira BioSciences, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.45B
- P/E
- 103.8
Eton Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.41B
- P/E
- 123.3
Cronos Group Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.25B
- P/E
- 17.8
Knight Therapeutics Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$1.15B
- P/E
- 78.0
Amphastar Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.11B
- P/E
- 15.5
Harrow, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.06B
- P/E
- unprofitable
Collegium Pharmaceutical, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $746.01M
- P/E
- 18.0
Ironwood Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $586.60M
- P/E
- 4.6
Evotec SE
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $554.41M
- P/E
- unprofitable
Aquestive Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $512.09M
- P/E
- unprofitable
Evolus, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $488.77M
- P/E
- unprofitable
Kamada Ltd.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $448.99M
- P/E
- 20.5
- Dividend Yield
- 2.17%
Tilray Brands, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $431.54M
- P/E
- unprofitable
Canopy Growth Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$422.34M
- P/E
- unprofitable
Auxly Cannabis Group Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$346.87M
- P/E
- 14.0
Cipher Pharmaceuticals Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$338.27M
- P/E
- 8.7
Emergent BioSolutions Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $317.89M
- P/E
- unprofitable
Alpha Teknova, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $314.08M
- P/E
- unprofitable
Anika Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $275.69M
- P/E
- unprofitable
Showing 1–50 of 97 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data. Ranked by market capitalization. Prices are the most recent daily close.
Which Drug Manufacturers - Specialty & Generic Stocks Are Reasonably Valued?
Prices: Oct 21, 2026 closeAmong the 50 largest Drug Manufacturers - Specialty & Generic companies, Ironwood Pharmaceuticals, Inc. (IRWD) trades at the lowest trailing P/E ratio, 4.6. The industry average is 38.8.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. | IRWD | $3.55 | $586.60M | 4.6 | — |
| Cipher Pharmaceuticals Inc. | CPH.TO | CA$13.31 | CA$338.27M | 8.7 | — |
| Indivior Pharmaceuticals, Inc. | INDV | $34.79 | $4.11B | 12.5 | — |
| Zoetis Inc. | ZTS | $79.62 | $32.90B | 13.1 | 2.65% |
| Prestige Consumer Healthcare Inc. | PBH | $47.92 | $2.27B | 13.4 | — |
Ranked by trailing twelve-month P/E, lowest first. Companies that report no P/E are not listed. Rankings cover the 50 largest Drug Manufacturers - Specialty & Generic companies by market capitalization.
Which Drug Manufacturers - Specialty & Generic Stocks Pay the Highest Dividends?
Prices: Oct 21, 2026 close9 of the 50 largest Drug Manufacturers - Specialty & Generic companies pay a dividend. Perrigo Company plc (PRGO) has the highest yield at 7.17%.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Perrigo Company plc | PRGO | $15.91 | $2.20B | 7.17% | |
| Takeda Pharmaceutical Company Limited | TAK | $19.93 | $63.67B | 3.07% | |
| Zoetis Inc. | ZTS | $79.62 | $32.90B | 13.1 | 2.65% |
| Viatris Inc. | VTRS | $18.45 | $21.19B | 2.57% | |
| Kamada Ltd. | KMDA | $7.78 | $448.99M | 20.5 | 2.17% |
Ranked by trailing dividend yield, highest first. Companies that pay no dividend are not listed. Rankings cover the 50 largest Drug Manufacturers - Specialty & Generic companies by market capitalization.
Key facts
As of October 21, 2026, 97 Drug Manufacturers - Specialty & Generic stocks are listed: 83 on NYSE & NASDAQ and 14 on TSX (Toronto Stock Exchange). A company listed on more than one exchange is counted once.
The largest by market capitalization is Takeda Pharmaceutical Company Limited (TAK) at $63.67B.
The median P/E across the Drug Manufacturers - Specialty & Generic industry is 20.3.
Drug Manufacturers - Specialty & Generic Industry Overview
From the data · Oct 21, 2026The Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, includes 97 publicly traded companies with a combined market capitalization of $357.07B in US dollars. A further CA$13.75B is quoted in CAD, across 14 listed companies. The industry is led by Takeda Pharmaceutical Company Limited (TAK), Teva Pharmaceutical Industries Limited (TEVA), Haleon plc (HLN).
Among the 97 listed Drug Manufacturers - Specialty & Generic companies, market capitalizations range from $63.67B (Takeda Pharmaceutical Company Limited) down to $756.10K (China SXT Pharmaceuticals, Inc.), highlighting the wide size disparity across the industry.
Drug Manufacturers - Specialty & Generic Industry Valuation
The Drug Manufacturers - Specialty & Generic industry currently trades at an average price-to-earnings (P/E) ratio of 38.8. This elevated multiple indicates that investors are pricing in strong future earnings growth across Drug Manufacturers - Specialty & Generic companies. Note that some companies in the industry report no P/E ratio, typically because they are currently unprofitable or in early growth stages.
Drug Manufacturers - Specialty & Generic Dividend Profile
9 out of 97 Drug Manufacturers - Specialty & Generic companies (9%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Drug Manufacturers - Specialty & Generic stocks is 2.40%. Most Drug Manufacturers - Specialty & Generic companies reinvest earnings into growth rather than paying dividends, which is typical for earlier-stage or high-growth industries.
Frequently Asked Questions
What are the leading Drug Manufacturers - Specialty & Generic stocks?
The largest Drug Manufacturers - Specialty & Generic stocks by market capitalization are Takeda Pharmaceutical Company Limited (TAK), Teva Pharmaceutical Industries Limited (TEVA), Haleon plc (HLN), Zoetis Inc. (ZTS), United Therapeutics Corporation (UTHR). All 97 companies are ranked by market cap on this page.
Where can I find a complete list of Drug Manufacturers - Specialty & Generic stocks?
This page is the complete list: 97 Drug Manufacturers - Specialty & Generic companies across 2 page(s), 50 per page, ranked by market capitalization — including TAK, TEVA, HLN, ZTS, UTHR.
How many Drug Manufacturers - Specialty & Generic stocks are there?
There are 97 publicly traded Drug Manufacturers - Specialty & Generic companies: 83 on NYSE & NASDAQ and 14 on TSX (Toronto Stock Exchange). By market capitalization, they range from Takeda Pharmaceutical Company Limited (TAK) to China SXT Pharmaceuticals, Inc. (SXTC). A company listed on more than one exchange is counted once. This directory spans 2 pages, with all companies sorted by market cap for easy comparison.
Which Drug Manufacturers - Specialty & Generic stocks are reasonably valued?
Among the 50 largest Drug Manufacturers - Specialty & Generic companies, Ironwood Pharmaceuticals, Inc. (IRWD) carries the lowest trailing P/E at 4.6, against an industry average of 38.8.
Which Drug Manufacturers - Specialty & Generic stocks have the highest dividend yield?
9 of the 97 Drug Manufacturers - Specialty & Generic companies (9%) pay a dividend, with an average yield of 2.40% among payers. The highest yield among the 50 largest is Perrigo Company plc (PRGO) at 7.17%.
Explore Drug Manufacturers - Specialty & Generic Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 97 Drug Manufacturers - Specialty & Generic companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Drug Manufacturers - Specialty & Generic stocks head to head. All data is updated regularly to reflect the latest available financials.